Most Drug and Substance changes have been presented in the recent Alpha release, however the numbers are still evolving and will likely change before the final version of the release notes are generated in July. Some of the changes include Use of additional Axioms, which is explained in details in this briefing
Briefing note - Use of Additional Axiom Functionality and Remodeling Product Roles.pdf